Few industries show as much promise in innovation as healthcare. One example is the development of drugs to treat diabetes and obesity. Approximately 800 million people globally were defined as or considered obese in 2020, and that number is expected to grow to more than 1.2 billion people by 2030.* Companies, however, have made huge strides in treating these and related health issues, offering an extraordinary opportunity for investors.